Table 1.
Concn of NCTb (mM) | PT (%) | aPTT (s) | TT (s) | Fibrinogen concn (mg/dl) |
---|---|---|---|---|
55 (1) | < limit | > limit | > limit | Not detectable |
27.5 (0.5) | < limit | > limit | > limit | Not detectable |
13.8 (0.25) | < limit | > limit | 101.8 | Not detectable |
5.5 (0.1) | < limit | 371.4 | 92.2 | Not detectable |
2.75 (0.05) | 33.4 | 71.3 | 48.8 | Not detectable |
1.38 (0.025) | 70.6 | 37.7 | 26.6 | 199.4 |
0.55 (0.01) | 91.4 | 30.6 | 19.5 | 281.4 |
0 NCT, salinec | 89.3 | 29.9 | 19.5 | 289.5 |
0 NCTd | 100.1 | 29.1 | 19.6 | 388.3 |
Results are from a single pilot experiment. PT, prothrombin time; aPTT, activated partial thromboplastin time; TT, thrombin time. > limit/< limit, value exceeded/went below the test limit.
NCT was dissolved in saline and 10-fold diluted in whole human citrate blood (0.2 ml plus 1.8 ml). Data in parentheses are percentages.
Blood (1.8 ml) plus 0.2 ml physiological saline solution.
Citrate blood without any additives.